000 | 02018ngm a2200469 a 4500 | ||
---|---|---|---|
001 | HST5719 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 220304s2022 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a5719 _bHenry Stewart Talks |
035 | _a(UkLoHST)4877 | ||
040 |
_aUkLoHST _beng _cUkLoHST |
||
100 | 1 |
_aLowdell, Mark, _u(University College London, UK) _4spk |
|
245 | 1 | 0 |
_aATMPs from academia to industry _h[electronic resource] : _bgetting it right first time (GIRFT) / _cMark Lowdell. |
246 | 3 | _aAdvanced Therapy Medicinal Products from academia to industry : getting it right first time | |
260 |
_aLondon : _bHenry Stewart Talks, _c2022. |
||
300 |
_a1 online resource (1 streaming video file (41 min.) : _bcolor, sound). |
||
490 | 1 |
_aThe biomedical & life sciences collection, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from title frames. | ||
505 | 0 | _aContents: Advanced Therapy Medicinal Products (ATMPs) -- ATMP development -- Requirements for a successful ATMP -- Challenges in commercial drug development -- Getting It Right First Time (GIRFT) -- The uniqueness of ATMP. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 0 | _aAcademic-industrial collaboration. | |
650 | 0 |
_aBiotechnology _xLaw and legislation. |
|
650 | 0 | _aCellular therapy. | |
650 | 0 | _aDrug development. | |
650 | 0 | _aGene therapy. | |
650 | 0 | _aPharmaceutical industry. | |
650 | 0 | _aRegenerative medicine. | |
650 | 0 |
_aStem cells _xResearch. |
|
650 | 2 | _aCell- and Tissue-Based Therapy. | |
650 | 2 |
_aDrug Development _xmethods. |
|
650 | 2 |
_aDrug Development _xtrends. |
|
650 | 2 | _aGenetic Therapy. | |
650 | 2 | _aMesenchymal Stem Cells. | |
650 | 2 |
_aTranslational Research, Biomedical _xtrends. |
|
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/4877/ |
999 |
_c75587 _d75587 |